Mr. Mathias Uhlén is a Co-Founder and serves as Chairman at Atlas Antibodies. He co-founded and served as Deputy Chairman and Scientific Advisor at Affibody. He serves as Board Member at Bure Equity. Dr. Uhlén serves as Professor at Royal Institute of Technology. Dr. Uhlén serves as a Board Member at SweTree Technologies and Affibody. Mathias Uhlén is Professor of Microbiology at the Royal Institute of Technology, Stockholm, Sweden. Prof Uhlén is member of the Royal Swedish Academy of Engineering Science (IVA) and he is also a member of the Royal Swedish Academy of Science. He also serves as Board Member at Bure Equity.